RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS

Introduction. The anthracycline antibiotics cause clinically significant manifestations of cardiotoxicity (СТ) – myocardial injuries, reducing both quality and life expectancy of the oncological patients.The purpose of the study was to evaluate the incidence and risk factors anthracycline-induced СТ...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: N. T. Vatutin, E. V. Sklyannaya, M. A. El-Khatib, I. A. Sologub
Natura: Articolo
Lingua:russo
Pubblicazione: ABV-press 2017-10-01
Serie:Онкогематология
Soggetti:
Accesso online:https://oncohematology.abvpress.ru/ongm/article/view/255
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!